Incyte enters collaboration & license pact with Novartis for 2 haematology-oncology therapies
Friday, November 27, 2009 18:00 IST Wilimington, Del
Incyte Corporation has entered into a collaboration and license agreement with Novartis for two of its investigational haematology-oncology therapies: INCB18424, an oral JAK1/JAK2